← 產業報告目錄
Theranostics Market Size, Share & Trends Analysis Report, By Product (Diagnostic imaging, Radiopharmaceuticals, Biomarker screening and Software), Application (Prostate Cancer, Bone Metastasis, Other Cancers, Other Application), End-user (Hospitals & Cancer Care Centers, Theranostics Centers, and Research & Academic Centers), By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-04頁數 179報告編號 INSIGHTACE-118cb82eeb
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
In 2023, the Theranostics Market worldwide was assessed at USD 2.21 Bn. Analysts project it will develop to USD 6.37 Bn by 2031, at a CAGR of 14.38% spanning 2024 to 2031.
Theranostics covers Theranostics involves and another for therapy, to treat the original tumor and any metastasized tumors. Rapid advancements and evolving end-user preferences are reshaping how healthcare entities approach this space.
Growth is driven by a convergence of factors: rising awareness among end users, continuous product innovation, and the rising emphasis on efficiency and sustainability within the healthcare sector.
From a segmentation standpoint, the market is categorized across multiple dimensions including product type, application, end-user, and geography, each exhibiting distinct growth patterns and opportunities.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, driven by rapid industrialization and expanding end-user bases.
Competition in this space is characterized by active product development, strategic collaborations, and geographic expansion among both global leaders and specialized niche players.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Theranostics Market Snapshot
Chapter 4. Global Theranostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis
5.1. by Product & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product:
5.2.1. Diagnostic Imaging
5.2.2. Radiopharmaceuticals
5.2.3. IVD/Biomarker Screening
5.2.4. Software and Services
Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:
6.2.1. Prostate Cancer
6.2.2. Bone Metastasis
6.2.3. Other Cancers
6.2.4. Other Applications
Chapter 7. Market Segmentation 4: by End-User Estimates & Trend Analysis
7.1. by End-User & Market Share, 2019 & 2031
7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by End-User:
7.2.1. Hospitals and Cancer Care Centers
7.2.2. Theranostics Centers
7.2.3. Research and Academic Centers
Chapter 8. Theranostics Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.1.2. North America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.1.3. North America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.1.4. North America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.2.2. Europe Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.2.3. Europe Theranostics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.2.4. Europe Theranostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.3.2. Asia Pacific Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.3.3. Asia Pacific Theranostics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.3.4. Asia Pacific Theranostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.4.2. Latin America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.4.3. Latin America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.4.4. Latin America Theranostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031
8.5.2. Middle East & Africa Theranostics Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031
8.5.3. Middle East & Africa Theranostics Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2019-2031
8.5.4. Middle East & Africa Theranostics Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. Advanced Accelerator Applications
9.2.2. Bayer AG
9.2.3. GE Healthcare
9.2.4. Siemens healthiness Ag
9.2.5. Cardinal Health
9.2.6. Philips Healthcare
9.2.7. Canon Inc
9.2.8. Curium
9.2.9. Lantheus
9.2.10. Northstar Medical Radioisotopes
9.2.11. Eckert & Ziegler
9.2.12. Pharmacologic
9.2.13. Eczacibasi -Monroe
9.2.14. Acrotech Biopharma Inc.
9.2.15. Other Prominent Players
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們